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This study was conducted to determine if the p38 and ERK1/2 MAPK pathways are 
involved in transcription of IL-6, IL-8, and COX-2 in the chicken thrombocyte response to 
ligation of Toll-like receptor 4 (TLR4) by Salmonella minnesota lipopolysaccharide (LPS).  
Thrombocytes were isolated and subsequently treated wi h either p38 MAPK or ERK inhibitor, 
and then with LPS during in vitro cell culture.  Transcription of IL-6, IL-8, and COX-2 mRNA 
was determined using real-time PCR.  The experiments were repeated using pM, nM and µM
concentrations of both inhibitors to test cell sensitivity.  Stimulation with LPS induced expression 
of IL-6, IL-8 and COX-2 mRNA.  This expression was reduced by treatment with 25 µM ERK 
inhibitor as well as by treatment with 70 µM p38 MAPK inhibitor.  However, treatment with 25 
pM and nM ERK inhibitor, and with 70 pM and nM p38 MAPK inhibitor, yielded no decrease in 
mRNA expression in relation to treatment with LPS alone.  Inhibition with both the ERK and p38 
MAPK inhibitors was in accordance with previously established concentrations for mammalian 
cells.  It is now apparent that the p38 and ERK1/2 MAPK pathways are both linked to gene 
expression of a cytokine, a chemokine and an enzyme involved in the thrombocyte innate 
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Avian Innate Immunity 
The innate immune system of aves is similar to that of mammals.  Many components such as 
cytokines, complement, and TLRs have proven to be highly conserved, with the exception of 
some blood cells (e.g., heterophils, thrombocytes).   
Chickens also have many of the same innate immune cells found in mammals.  Dendritic 
cells engulf, process, and present pathogens to naïve T cells using finger-like extensions.  
Immature dendritic cells circulate in the blood prior to migration into tissues.  At this point, they 
are capable of migrating to secondary lymphoid tissue to stimulate maturing T cells.  Monocytes 
and macrophages are also part of chicken innate immunity.  At the time of hatch, chicken 
macrophages are fully capable of phagocytosis (Qureshi et al, 2000).  Monocytes are leukocytes 
produced in the bone marrow which enter the bloodstream and, after a few days, migrate into the 
tissues.  Once in the tissues, they mature into macrophages.  Macrophages phagocytize, process, 
and present antigens complexed with class II MHC to stimulate sensitized T cells against the 
presented antigen.  
Interestingly, chickens lack the variety of granulocytes found in the mammalian immune 
system, including functional eosinophils (Vegad & Katiyar, 1995; Kaiser et al, 2005). The 
primary granulocyte is the heterophil, the avian counterpart to a neutrophil.  Like macrophages, 
heterophils are highly phagocytic.  In addition, they secrete proteolytic enzymes and reactive 
oxygen intermediates (Kogut et al, 2001; Swaggerty t al, 2003).  However, the contents of 
heterophilic granules differ significantly from those of neutrophils (Harmon, 1998).  They contain 
cationic peptides, lysozyme, acid phosphatase, acid hydrolases, Cathepsin, and α-glucosidase 
(Brune and Spitznagel, 1973; Rausch and Moore, 1975; Daimon and Claxton-Martins, 1977; 





mammalian natural killer (NK) cells.  They bear a phenotypic resemblance to mammalian NK 
cells and display cytotoxic activity against target c ll lines (Gobel et al, 1994).  These cells are 
large granular lymphocytes characterized by intracellular expression of CD3 and a lack of 
receptors definitive of B or T lymphocytes (Gobel et al, 1994).  It was previously believed that 
they were capable of cytolytic activity upon leaving the bone marrow, but in 2004 it was 
discovered that human NK cells require stimulation, possibly by T-cell secreted IL-2, for 
cytolytic activity to occur (Ferlazzo et al, 2004).  Unlike human NK cells, chicken NK cells do 
not express MHC class II (Gobel et al, 1994).  Chickens also have mast cells, which mediate 
anaphylaxis as well as the response to parasitic infe t on.  Chicken mast cells are similar to those 
in mammals, degranulating upon stimulation, to release histamine and other preformed mediators.  
Secreted factors act to recruit granulocytes, lymphocytes, and monocytes or macrophages to the 
site of infection (Lin & Befus, 1999).  In the avian gut, mast cell histamine release is associated 
with ion secretion leading to secretory diarrhea, which aids in bacterial clearance (Collins et al, 
2007).  Chicken mast cells are most prevalent in the ovaries and the lamina propria of the small 
intestine (Swayne and Weisbrode, 1990).  Our laboratory also observed them in the Harderian 
gland (Scott et al, 2005) lining the subepithelium of the ducts.  Rose et al (1980) found that they 
have the same preformed immune mediators as their mammalian counterparts. 
Chicken thrombocytes are the avian counterpart to mam alian platelets.  Like platelets, 
they primarily function in hemostasis, but in contrast to platelets, are nucleated.  This means that 
thrombocytes are capable of responding to external stimuli by altering gene expression.  They are 
morphologically similar to leukocytes, and also have  role in innate immunity and activation of 
acquired immunity (Traill et al, 1983).  Activated thrombocytes express a range of immune 
mediators including cytokines, chemokines, leukotrienes, and prostaglandins.  In addition to 





coagulation, these cells are also phagocytic, having many lysosomes containing acid phosphatase, 
basic proteins, and fatty acids (Wigley et al, 1999; Sweeny & Carlson, 1968).  They number 
between 20 and 30 thousand per milliliter of blood, and comprise over 90% of adherent cells in 
the peripheral blood, (Campbell, 1988; Grecci et al, 1980). Unlike heterophils, these cells are 
incapable of undergoing oxidative burst (Lam, 1997).  Thrombocytes are of interest because, 
among other reasons, they are the most abundant leukocytes in circulation.   
Mammalian platelets are formed by blebbing off large cells, megakaryocytes, located in 
the bone marrow.  Circulating platelets are generally viable for 7 to 10 days (Weiss, 1975).  Being 
non-nucleated, they have no genomic DNA, but do contain mRNA and transcriptional machinery 
derived from the megakaryocyte (Healy et al, 2006).  Interestingly, pre-mRNA, found only in the 
cell nucleus, has been detected in platelet cytoplasm (Denis et al, 2005).  Some primary 
transcripts found in platelets include TNF-β, IL-7, Stem Cell Factor, cMpl, IgE receptor subunits, 
and nuclear factor-E2, a transcription factor (Soslau et al, 1997).  When stimulated, they express 
new receptors for adhesive proteins, aggregate, and release cytokines (Gear and Camerini, 2003).  
Platelets also make direct contact with granulocytes, endothelial cells, monocytes, and 
lymphocytes in order to activate them (Halvorsen et al, 1993; Klinger, 1997; Gear and Camerini, 
2003).  Each cell has approximately 35 α granules containing platelet derived growth factor, 
clotting factors, and platelet factor 4 (Klinger, 1997).  They also have dense bodies containing 
serotonin, epinephrine, histamine, dopamine, ADP, ATP and calcium (Holmsen & Weiss, 1979; 
Wurzinger, 1990).   
 Avian thrombocytes express many of the same receptors and secreted factors as platelets.  
These include CD40L, which binds to the CD40 on B cells to aid in stimulation and survival, on 
macrophages to stimulate nitric oxide synthesis, and on bursal lymphoma cells to induce 





glycoproteins IIb and IIIa, which mediate cohesion leading to formation of the hemostatic plug 
(Kunicki & Newman, 1985).  Thrombocytes also express MIP-1β, a chemokine that recruits and 
activates granulocytes, and platelet derived growth factor, which stimulates angiogenesis (Lam, 
2002; Horiuchi et al, 2001).  Other factors include β-thromboglobulin, a marker of thrombocyte 
activation, anti-apoptotic factors, lysosomal compounds, and B-G associated class III MHC 
antigens (Wachowicz and Krakewski, 1979; DaMatta et l, 1999; Taffarel and Oliveira, 1993; 
Daimon and Uchida, 1982; Salomonsen et al, 1991).   
As research on thrombocytes has accumulated, it hasbecome obvious that these cells 
serve a role in more than just coagulation and phagocytosis.  It is now clear that they are integral 
in the avian response to pathogenic invasion.  Traill et al (1983) demonstrated that anti-bursal cell 
serum identifies markers common to B cells and thromb cytes.  Higashihara et al (1986) showed 
that thrombocytes share a polypeptide with MDCC-MSB1 cells.  The K1 antibody, which has 
been used to discriminate thrombocytes from B and T cells via flow cytometry, binds a 
heterodimeric adhesion molecule expressed on both macrophages and thrombocytes of the 
chicken (Kaspers et al, 1993; Bohls et al, 2005).  Anti-VLA4 recognizes markers on 
thrombocytes, hematopoietic progenitor cells, and eosinophils (McNagny et al, 1992).  Along 
with the numerous secreted immune modulators, thrombocytes have many surface antigens 
characteristic of immune cells. 
 It has been demonstrated that avian thrombocytes express multiple TLRs, a critical and 
highly conserved component of the innate immune system in vertebrates (T. Scott and M. Owens, 
unpublished data).  Bursal cDNA was first used to demonstrate the presence and functionality of 
chicken TLR2 (Fukui et al, 2001).  More recently, differential induction of nitric oxide via TLR 
ligation was demonstrated in turkey monocytes (He et al, 2008).  Scott and Owens (2008) 





intracellular signal pathways.  This work demonstrated not only that these cells respond to a 
pathogen associated molecular pattern (PAMP) via a highly conserved MAPK pathway, but also 
that they express IL-6 and COX-2 in response to bacteri l stimulation (Scott and Owens, 2008). 
Pathogen recognition often begins with binding of abacterial or viral component such as 
lipopolysaccharide or dsRNA by a TLR.  Ligation of TLRs results in activation of specific signal 
pathways, many of which are also highly conserved.  Initiation of the intracellular signal leads to 
alteration of gene expression and results in production of some type of response, such as secretion 
of pro-inflammatory molecules.   
Chickens express many orthologues of human TLRs.  Thus far, orthologues of mammalian 
TLR-1 -2, -3, -4, -5, -7, and one similar to TLR-1, 6, and 10 have been identified.  These will be 
discussed further below. 
Avian cells express an array of cytokines that is more narrow in scope compared to 
mammalian systems (Hughes et al, 2007).  Cytokines ar  ecreted glycopeptides that bind 
specific target receptors, initiating an intracellular signal cascade.  Depending on the cytokine and 
target cell, the signal cascade leads to a response, ften a change in gene expression.  Cytokines 
can be subdivided into interleukins (IL), tumor necrosis factors (TNF), transforming growth 
factors (TGF), interferons (IFN), colony stimulating factors (CSF), macrophage inflammatory 
protein (MIP) and monocyte chemoattractant protein (MCP).   In general, there is low homology 
between avian and human cytokine sequences (Kaiser et al, 2005).   
In the IL subclass of cytokines, chickens express orthologues to IL-1β, -10, -19, -22, -26, four 
subtypes of IL-17, most TH1, TH2, and T cell-proliferative interleukins, and IL-3, 6, 7, 9, and 16 
(Kaiser et al, 2005).  Most ILs are expressed by leukocytes, although many non-immune cells 
secrete them as well.  They serve a variety of functio s, including recruitment of immune cells to 





IFNs are secreted by immature dendritic cells and virally infected cells in response to 
infection or tumor growth.  They inhibit viral RNA production (Type I) and activate (Type II) 
natural killer cells and macrophages. In chickens, orthologues to human IFN-α, -β, and –γ have 
been discovered thus far (Guo et al, 2008).  Ligation of many IFN receptors results in activation 
of the JAK/STAT signal pathway and p53-mediated apoptosis in target cells.  IFNs also initiate or 
upregulate expression of certain genes, such as that for the Myxovirus resistance protein (Mx).  
This protein has intrinsic GTPase activity and is used for sensing the presence of “nucleocapsid-
like structures” during infection.  It also traps viral components in areas of the cell where new 
viral particles cannot be assembled (Li et al, 2007).  Ligation of IFN receptors also leads to 
production of Very Large Inducible GTPase 1 (VLIG-1) (Guo et al, 2008).  This is a large 
enzyme that regulates transcription of hundreds of genes involved in pathogen defense (Klamp et 
al, 2003). 
TNFs bind target receptors to initiate a signal cascade leading to cell death via the caspase 
pathway.  Chickens express ten known TNF-like cytokines (Kaiser et al, 2005).  They bind target 
receptors on endothelial cells to increase vascular permeability, thus allowing an influx of 
immune cells and other inflammatory molecules.  Most TNF receptors are type II transmembrane 
proteins, meaning they make a single pass through the lipid bilayer, and the N-termini lie on the 
cytoplasmic face of the plasma membrane. 
Chemokines, a subclass of cytokines, are 67-127 amino acid-long glycoproteins that function 
to draw immune cells into an area of damage or site of infection.  Most are secreted, but a few 
exist which are membrane-bound (Kaiser et al, 2005).  The chicken repertoire of chemokines 
differs significantly from that of mammals (Guo et al, 2008).  Chemokines are categorized into 
subfamilies based on the first two N-terminal cysteine residues.  In CXCL chemokines, these 





subfamily.  XCL chemokines have only two cysteine residues, with one near the N terminus and 
the other downstream.  The few known CX3 L chemokines have three amino acids separating the 
two N-terminal cysteines. 
Chemokines are a critical component of the innate arm of the immune system.  They can have 
endocrine, paracrine, or autocrine function, and meiat  inflammation as well as hematopoiesis.  
Thus far, orthologue genes to human CCL-1 through -5, -8, 11, -13, -15, -16, -18, and -23 have 
been discovered.  In addition, orthologues to CXCL-1 through -8, CXCL-12 through -14, 
CX3CL1, and XCL-1 have been discovered (Kaiser et al, 2005).  CCL chemokines are grouped 
into the MIP and MCP families (Kaiser et al, 2005).  Functionally, chemokines are divided into 
those which enhance cytokine (type I) responses and those that enhance antibody (type II) 
responses.  Some chicken cytokines with known functio s include CXCR4, which is involved in 
regulation of progenitor cell trafficking, XCL-1, which is a T cell chemoattractant, CXCL13, a B 
cell attractant, and CAF, a chemotactic and angiogenic factor (Tamamura et al, 2006; Moser et al, 
2004; Kaiser et al, 2005).  Ah294 is a possible orthologue of mammalian CCL5, which is a 
chemoattractant for monocytes, memory TH cells, and eosinophils (Hughes et al, 2007).  
Phylogenetic analysis groups the chicken ah221 genewith the mammalian MCP family of 
cytokines (Hughes et al, 2001). 
 
Toll-like Receptors 
TLRs are highly conserved members of the IL-1 receptor family that can be found on cell 
surface and internal compartment membranes across many animal phyla (Boyd et al, 2007).  They 
were named for their structural similarity to a protein coded by the Drosophila Toll gene which is 
required for the establishment of the dorsal-ventral axis in developing larvae (Medzhitov et al, 





system.  Members of IL-1R family share an approximately 200 amino acid cytoplasmic region 
called a TIR (Toll/IL1R) domain.  Extracellular regions contain leucine-rich repeat domains 
(Akira, 2003).  All TLRs have leucine-rich repeats and one or two cysteine-rich regions in the 
ligand-binding region of the external domain (Kindt et al, 2007).  A short transmembrane domain 
spans the plasma membrane.  The cytoplasmic, or TIR (Toll/IL-1R) domain of these receptors is 
structurally similar to the cytoplasmic domain of the IL-1 receptor, and is very much homologous 
among the different TLRs.   
At present, eleven TLRs have been identified in humans and mice.  Eight human orthologues 
have been identified in chickens (Iqbal et al, 2005).  Most TLRs function as either hetero- or 
homodimers, and all bind to a specific bacterial or viral component.  Collectively, these 
components are called pathogen associated molecular patterns (PAMPs), and are conserved 
among the types of pathogens in which they are found.   
Mammalian TLRs that reside on internal membranes include TLR-3, -7, -8, and -9.  These 
internal receptors bind PAMPs found inside infected c lls, including double- and single-stranded 
viral RNA, and CpG dinucleotides of bacterial DNA.  TLR-1 and -2 dimerize on the plasma 
membrane to bind components of bacterial parasites (Kindt et al, 2007).  TLR-2 and -6 dimerize 
to bind components of gram positive bacteria and fugi (Kindt et al, 2007).  TLR-4 monomers 
come together to bind lipopolysaccharide (LPS), a major component of gram negative bacterial 
cell walls.  This homodimer also binds the F protein of respiratory syncytial virus.  Finally, TLR-
5 forms a homodimer to bind flagellin (Kindt et al,2007).  The functions of human TLR-10 and -
11 are at present unknown. 
In the avian immune system, human orthologues of TLR-1 through TLR -7 have been 
identified (Iqbal et al, 2005).  To date, no avian orthologues of TLR-8, -9, or -10 have been 





of chicken TLR-2 have been reported, and interrupted remnants of the gene for one of these 
isoforms was discovered in the human genome, suggestin  that gene duplication occurred prior to 
the divergence of mammals and birds 300 million years ago (Boyd et al, 2007).  While the two 
isoforms of chicken TLR2 share 88.5% nucleic acid identity, only isoform 2 has demonstrated a 
strong response to classic mammalian TLR2 agonists (Fukui et al, 2001).  Both TLR-2 and -4 
share around 50% amino acid sequence identity with the human counterparts, and evidence 
suggests that these TLRs were distinct before the divergence of mammals and birds (Yilmaz et al, 
2005). 
As in mammals, TLR4 ligation is responsible for eliciting the avian immune response to LPS.  
It was previously believed that TLR2 isoform 2 bound LPS to initiate this response, but a 2008 
study revealed that this response is generated exclusive y by TLR4 in conjunction with MD 
(myeloid differentiation protein)-2 (Keestra & van Putten, 2008). In the mammalian system, LBP 
binds LPS and transfers it to CD-14, which then delivers the molecule to MD-2 (Pallson-
McDermott & O’Neill, 2004).  The conformational change induced in MD-2 by LPS ligation 
triggers transfer of the molecule to TLR4 (Kim et al, 2007; Ohto et al, 2007).  In this study, a 
protein similar to CD14 was discovered, but no orthlogue to LBP was apparent (Keestra & van 
Putten, 2008).  It seems, however, that CD14, MD-2, and LPS interaction during initiation of the 
LPS response is similar in chickens and mammals (Keestra & van Putten, 2008). While all other 
known TLRs aside from TLR3 activate only MyD88-depend nt signal pathways, TLR4 ligation 
recruits multiple adapter molecules, namely TIRAP (in the MyD88 dependent pathway), TRAM 
(TRIF-related adapter molecule), and TRIF (TIR-domain-containing adapter-inducing IFN-β) 
(Keestra & van Putten, 2008).  Dual activation of TRIF and TRAM is unique to the TLR4- 
activated pathway (Yamamoto et al, 2003).  The authors of this publication attribute the previous 





genetic lines of chickens, TLR4 has been mapped to a gene region associated with susceptibility 
to Salmonella infection (Leveque et al, 2003).   
TLRs are highly conserved receptors, the ligation of which activates highly conserved 
intracellular signal cascades.  Activation of these cascades leads to a variety of responses, 
depending on the ligand and cell type.  TLRs are a critical component of the innate immune 
system in all animal phyla examined to date.  TLR4, in particular, allows immune cells such as 
avian thrombocytes and mammalian macrophages to initiate a local response to invading gram 
negative bacteria through activation of both MyD88-dependent and -independent MAPK 
pathways. 
Intracellular Signal Cascades in the Innate Immune Response 
Ligation of all TLRs induces activation of intracellular signaling cascades.  In particular, the 
p38 mitogen-activated protein kinase (MAPK), extracellular-signaling regulated kinase (ERK), 
and Nuclear factor (NF)-κB pathways are activated.  Induction of these pathwys via TLR 
ligation activates cell-mediated immunity, apoptosis, antimicrobial peptide production, or pro-
inflammatory molecule production.  TLR ligation recruits MyD88 to the TIR domain of the 
receptor.  The IRAK1/IRAK4 complex then docks on MyD88, and IRAK4 phosphorylates 
IRAK1, creating a binding site for TRAF6.  The newly formed IRAK1/TRAF6 complex 
dissociates from IRAK4 to activate TAK1.  From this point, TAK1 may activate IKK in the 
NFkB or MEK in the p38 MAPK pathway.  TAK1 also leads to activation of TPL2, which then 
activates MKK1/2 in the ERK1/2 pathway (Banerjee & Gerondakis, 2007).  
ERK1/2 can be found in varying levels in all tissue (Chen et al, 2001).  Activation of the 
ERK pathway via TLR4 ligation begins with recruitment of Ras to the cytoplasmic tail of TLR4.  
Ras binds temporarily to a docking site on the tail and recruits Raf1.  Raf1 phosphorylates and 





ERK1/2 is then free to enter the nucleus and activate Elk, a transcription factor.  Ligation of 
peptidoglycan by TLR2 and CpG by TLR9 also induce ativ tion of the ERK pathway via Ras.  
However it is important to note that ERK activation via TLR4 ligation is Ras-independent (Chen 
et al., 2004; Xu et al., 2003; David et al., 2005).  The ERK pathway has traditionally been linked 
to cell survival and proliferation, but recent research shows that it is also integral to the innate 
immune response (Roux & Blenis, 2004; Galdiero et al, 2005).   
Inhibition of MEK1/2 in the ERK pathway in U937 human monocytic leukemia cells as well 
as in chicken thrombocytes has led to decreased mRNA expression of TNF-α, IL-1β, and COX-2 
(Galdiero et al, 2005; Scott & Owens, 2008).  Interestingly, LPS-induced expression of IL-6 and -
8 are unchanged in U937 cells after treatment with PD98059 (Galdiero et al, 2005).  However, 
LPS-induced expression of IL-6 and TNF were suppressed in alveolar macrophages treated with 
MEK1 inhibitor PD98059 (Carter et al, 1999). 
TLR-4 ligation also leads to activation of the p38 MAPK cascade.  This pathway, unlike the 
ERK pathway, has traditionally been linked to inflammation (Chae et al, 2005).  Ligation leads to 
activation of TAK, which phosphorylates and activates MEK3/6.  MEK3/6 then phosphorylates 
and activates p38.  This molecule then enters the nucleus and activates MSK1/2 which leads to 
transcription of pro-inflammatory molecules, including IL-6, IL-1, TNF-α and IL-8 (Galdiero et 
al, 2005; Scott and Owens, 2008). 
Inhibition of p38 suppresses LPS-induced production of TNF-α, IL-6, and IL-10 in humans 
(Kaminska, 2005).  As with the ERK pathway, inhibition of the p38 MAPK pathway using 
SB203580 significantly lowered the levels of IL-6 and TNF produced in human alveolar 
macrophages stimulated with LPS (Carter et al, 1999).  In contrast, Galdiero et al (2005) found 





were treated with SB203580.  In murine macrophages, this pathway is apparently critical for 
expression of IL-6 and -12 (Zhu et al, 2005).   
Despite varying results for expression of specific cytokines, it is clear that the p38 MAPK 
and ERK pathways are critically involved in inflammation.  Furthermore, these pathways appear 
to be highly conserved, as their involvement in regulation of the inflammatory response has been 
demonstrated in mice, humans, and chickens, among others (Zhu et al, 2005; Galdiero et al, 2005; 
Scott and Owens, 2008; Aggeli et al, 2001).   
The present study is an expansion upon previous resea ch in our laboratory, which 
demonstrated the involvement of the ERK and NFκB pathways in the thrombocyte inflammatory 
response to LPS stimulation.  This work has been expanded to include the p38 MAPK pathway, 
which, in many other organisms, is integral in the inflammatory response.  In addition, this study 
has focused on the involvement of MAPKs rather than MAPKKs in the expression of 
inflammatory molecules.  Expression of a cytokine, a chemokine, and an enzyme in response to 
LPS stimulation was examined.  It was found that both the ERK and p38 MAPK pathways are 
involved in the thrombocyte response to LPS, and that both pathways regulate expression of 








Avian thrombocytes serve a similar hemostatic functio  as mammalian platelets and are 
the most numerous of all chicken leukocytes, playing a  integral role in innate immunity 
(Horiuchi, et. al, 2004).  Thrombocytes bind bacterial lipopolysaccharide (LPS) through TLR4, 
which initiates an inflammatory response (Ferdous et al., 2008; Scott and Owens, 2008).  Part of 
the general innate response is the production of pro-inflammatory molecules including IL-6, IL-8 
and cyclooxygenase-2 (COX-2).  IL-6, a cytokine, initiates an inflammatory response to 
pathogens, activates both T and B lymphocytes, and promotes the differentiation of monocytes 
into macrophages (Gessani et al., 1993; Burdin et al., 1995; Rincon et al., 1997).  IL-8, a CXC 
chemokine, is released locally at sites of infection or tissue damage.  Upon release, this 
chemokine acts as a chemoattractant, recruiting heterophils which are activated to further enhance 
inflammatory responses to pathogens.  COX-2 is an enzyme that catalyzes the initial conversion 
of arachadonic acid to various prostanoids, primarily PGE2, PGD2, and thromboxane A2.  
Prostanoids are then released by cells to act as infl mmatory mediators affecting surrounding 
tissues (Herlong and Scott, 2006). 
Unlike thrombocytes, mammalian platelets lack nuclei and thus also the capacity to 
respond to pathogenic invasion through gene expression.  Platelets do, however, store CC and 
CXC chemokines, cationic peptides, interleukins, and dhesive compartmentalized α-granules 
(Klinger and Jelkmann, 2002).  Upon stimulation by contact with foreign pathogens, platelets 
may degranulate, releasing antimicrobial peptides and inflammatory mediators (Boehlen and 
Clemetson, 2001).  It has also been shown that platelets are capable of aggregating, engulfing 
bacteria and viruses into vacuoles, and then fusing vacuoles with α-granule containing 





Ferdous et al. (2008) found that incubating chick thrombocytes with LPS led to a 
significant increase in the expression of pro-inflammatory cytokines, specifically IL-1β, IL-6 and 
IL-12.  Scott and Owens (2008) reported that LPS exposure activated the NF-κB and MEK signal 
pathways through TLR4 ligation, and this led to signif cantly increased gene expression of IL-6 
and COX-2, with increased production of PGE2.  These two studies by our laboratory were the 
first published reports to show increased pro-inflammatory gene expression in thrombocytes 
resulting from exposure to LPS.  Once gene expression was demonstrated through LPS 
activation, Scott and Owens (2008) showed that inhib tion of MEK1 by PD98059 blocked this 
LPS-induced gene expression, implicating the involvement of this pathway in the expression of 
pro-inflammatory responses.  That study also demonstrated that inhibition of IKK with inhibitor 
BMS345541 significantly reduced the LPS-induced gene xpression, documenting the 
involvement of the NF-κB pathway in the thrombocyte pro-inflammatory response. 
The current study focused on the effects of inhibiting specific signaling molecules in two 
MAPK pathways that are implicated in the expression of three pro-inflammatory gene products- a 
cytokine, a chemokine and an enzyme- in response to TLR4 binding LPS.  SB203580 was used to 
inhibit p38, which is directly downstream of MEK3/6 in one of the MAPK pathways.  An 
inhibitor was used to suppress the activity of ERK, which is directly downstream of MEK1/2 in 
another MAPK pathway.  These signal molecules were chosen for inhibition because previous 
studies in our laboratory have demonstrated the involvement of MEK in pro-inflammatory gene 
expression via ERK activation, but it was undetermined what role the p38 MAPK pathway would 
have in chicken thrombocyte gene expression for inflammatory responses.  Previously, Scott and 
Owens (2008) were able to inhibit COX-2 gene expression if MEK1/2 was blocked by PD98059.  
IL-6 was unaffected by this inhibitor at the concentration used.  Also, there was no prior 





binding with LPS.  It was supposed, but unknown, that blocking of ERK instead of MEK1/2 
would lead to the same altered gene expression previously observed (Scott and Owens, 2008).  
This particular pathway, unlike the p38 MAPK pathway, has usually been associated with cell 
growth and differentiation rather than initiation of pro-inflammatory responses (Chae et al., 
2005).  The p38 MAPK pathway, on the other hand, has been linked to induction of pro-
inflammatory gene expression (Widmann et al., 1999).  Since thrombocytes are terminal-stage 
cells incapable of further proliferation, would the role of the MEK1/2 to ERK transduction be 
different for a cell type completely committed to innate immunity?  When MEK1/2 was inhibited 
in Scott and Owens’ study (2008), there was a departure of effect between IL-6 and COX-2 gene 
expression.  Would inhibition at the ERK level reveal a similar departure or would gene 
expression for IL-6, IL-8 and COX-2 all be decreased when inhibition occurs at a level closer to 
the nucleus?  Also, would the assumed p38 MAPK’s role in expression of pro-inflammatory 
genes found in other innate cells (i.e. neutrophils, eterophils, and macrophages) be a working 
mechanism in chicken thrombocytes?  With these questions in mind, a series of experiments were 
conducted with the idea that more information could be gathered on TLR4 linked pathways and 
gene expression.  The data presented were derived fom both microarray analysis and real-time 












MATERIALS AND METHODS 
 
Thrombocyte Recovery 
Blood was obtained from 9 - 12 week old Single Comb White Leghorn (SCWL) female 
chickens.  Thrombocytes were isolated by gradient crifugation according to Scott and Owens 
(2008).  Viable cell counts were performed using the Trypan blue method and dilutions made so 
that each microcentrifuge culture tube contained 1 x 107 cells in a final volume of 1 milliliter. 
ERK and p38 MAPK Inhibitors and Thrombocyte Culture 
Five milligrams ERK inhibitor (Calbiochem) was resuspended in 1.0 mL dimethyl 
sulfoxide (DMSO), producing a 15 mM solution.  Inhibitor suspension was added to each ERK 
inhibitor-treated tube, resulting in a final inhibitor concentration of 25 µM.  An equal volume of 
DMSO was added to tubes not treated with inhibitor. One milligram SB203580, p38MAPK 
inhibitor (Calbiochem), was resuspended in 1.0 mL DMSO, producing a 2.6 mM solution. 
Inhibitor suspension was added to SB203580-treated tubes and an equal volume of DMSO was 
added to tubes not treated with inhibitor.  This resulted in a final inhibitor concentration of 70 
µM. 
 All tubes were then incubated at 41°C on a rocking platform for 30 min in a humidified 
water-jacketed incubator.  After 30 min, the tubes w re removed and 2 µL (10 µg/mL final 
concentration) of lipopolysaccharide from Salmonella minnesota was added to LPS treated tubes.  
Two microliters of DEPC treated water was added to those not treated with LPS.  All tubes were 
incubated at 41°C on a rocking platform for 60 min in a humidified water-jacketed incubator. 
The tubes were removed and centrifuged at 5000 x g for 120 s at room temperature. The 
resulting supernatant was removed and each cell pellet was resuspended in 100 µL RNAlater™ 






 Based upon effective inhibitory concentrations from mammalian cell treatment, final 
concentrations of 25 µM ERK inhibitor and of 70 µM p38 inhibitor were chosen.  To determine if 
these concentrations were appropriate for chicken thrombocytes, a preliminary experiment was 
performed.  Different treatments were applied to four tubes of cells for each inhibitor.  The first 
tube of cells served as a negative control and was not treated with LPS or inhibitor.  The second 
tube was treated with inhibitor alone, the third with LPS, and the fourth with both inhibitor and 
LPS.  Results are found in Appendix 1. 
RNA samples from control cells, LPS-stimulated cells, and cells treated with µM 
concentrations of each inhibitor with and without LPS stimulation were subjected to microarray 
analysis (C. Keeler, University of Delaware).  Approximately 4,000 genes potentially involved in 
TLR4-linked signal pathways were examined.  This wadone to verify our initial real-time PCR 
results and to further determine the scope of genes induced via TLR4 pathways.  These results are 
presented in Appendix 2.   
First Experiment 
In order to determine if there was a difference in response to the inhibitors between two 
different genetic lines of chickens, the preliminary experiment described above was repeated with 
the same concentrations of inhibitors.  However, both inhibitors were used in respective cultures 
in order to compare against the same DMSO control.  Blood was taken from six birds of each 
genetic line for each test. 
Second Experiment 
 Dilutions of both the ERK and p38 inhibitors were made in the pM, nM and µM range to 





repeated, with the addition of 25 pM and nM ERK inhibitor with and without LPS, and 70 pM 
and nM p38 inhibitor with and without LPS. 
RNA Isolation and Real-Time Reverse Transcriptase Polymerase Chain Reaction 
RNA from each tube of cells was extracted according to a previously established protocol 
(Scott and Owens, 2008), using a Qiagen RNeasy® kit with the addition of DNase digest.  The 
final RNA concentration in each treatment tube was determined using a spectrophotometer 
(Eppendorf BioPhotometer).   
Real-time RT-PCR was performed using the Quantitech SYBR Green RT-PCR kit 
(Qiagen).  Reactions were completed using 0.5 µM forward and reverse primers for GAPDH, IL-
6, IL-8 and COX-2 (Table 1).  Dilutions were made for all treatments so that each individual 
reaction contained 10 ng RNA in a volume of 8 µL.  Twelve microliters of master mix containing 
buffer, reverse transcriptase, water, and forward and reverse primers were added to each 
experimental reaction.  Two reactions per treatment p r bird were performed.  In addition, 
Treatment 1 (no inhibitor and no LPS) for each bird was repeated without reverse transcriptase as 
a negative control.  A “No Template” negative contrl with DEPC-treated water in place of RNA 
was used to ensure purity of master mix components.  The cycling profile was 50°C for 30 min. 
(reverse transcriptase), 95°C for 15 min. (DNA polymerase), 40 cycles of 94°C for 15 s 












mRNA Primer sequence (5’-3’) Accession No. 
Reference 
GAPDH F ATGCCATCACAGCCACACAGAAGA NM_204305 
 R GCACACGGAAAGCCATTCCAGTAA 
Targets 
IL-6 F ATGTGCAAGAAGTTCACCGTGTGC AJ309540 
 R TTCCAGGTAGGTCTGAAAGGCGAA 
IL-8 F TTTCAGCTGCTCTGTCGCAAGGTA  AJ009800 
 R CTTGGCGTCAGCTTCACATCTTGA 
COX-2 F TCCACCAACAGTGAAGGACACTCA M64990 
 R ATCCCACTCTGGATGCTCCTGTTT 
Table 1. Forward (F) and reverse (R) primer sets for chicken thrombocyte real-time reverse 
transcriptase polymerase chain reactions of glycerald hyde-3-phosphate dehydrogenase 










In order to determine treatment differences, least-squares analysis of variance was used to 
compare fold-change in mRNA expression of COX-2, IL-6 and IL-8.  When appropriate, post-
ANOVA comparisons of treatment means were accomplished by pairwise t-tests.  In cases where 
the inhibitor controls (inhibitor and no LPS) were not different from the overall untreated control 
(no inhibitor and no LPS), the data was presented in bar graphs with the overall untreated control 
























Both p38 MAPK and ERK Inhibitors Interfered With mRNA Expression in LPS- Stimulated 
Thrombocytes. 
In the experiment comparing expression of IL-6, IL-8 and COX-2 in two different genetic 
lines of chickens, no differences in expression of these molecules in response to LPS were found, 
so the data were pooled for genetic lines.  Between th  control cells (-/-/-) and those treated with 
LPS alone (+/-/-), expressions of IL-6, IL-8 and COX-2 mRNA were significantly different (Fig. 
1A, B and C).  There were also significant reductions in IL-6, IL-8 and COX-2 mRNA 
expressions for LPS stimulated cells treated with p38 MAPK (+/+/-) and ERK inhibitors (+/-/+) 









































Figure 1. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2) 
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without 
p38 MAPK inhibitor SB203580 (70 µM) or ERK inhibitor (25 µM), and then 1h incubation of 
thrombocytes (1 x 107) at 41°C in the presence or absence of S. minnesota  lipopolysaccharide 
(LPS: 10 µg/mL).  The mRNA expression of all three molecules varied relative to LPS and 




































































Varying Concentrations of Both p38 MAPK and ERK Inhibitors Interfered with mRNA 
Expression in LPS-Stimulated Thrombocytes. 
The effect of treating thrombocytes with varying con entrations of the two inhibitors 
resulted in varying expression patterns for the thre genes of interest.  For p38 MAPK inhibitor, 
IL-6 and IL-8 expression following LPS stimulation (+/-) was significantly elevated over that of 
unstimulated cells (-/-) (Fig. 2A and B), while the COX-2 response was elevated but not 
significantly (Fig. 2C).  Interestingly, all three pro-inflammatory indicators had high induction of 
mRNA following LPS stimulation and inhibitor pre-treatment at the pM concentration.  Gene 
expressions for all three were reduced at the nM concentration of p38 MAPK inhibitor, and the 
µM pre-treatment was effective in blunting LPS stimulated gene expression for all three. 
In the experiment using dilutions of ERK inhibitor, treatment with LPS alone (+/-) 
significantly induced the expression of IL-6, IL-8 and COX-2 over the control thrombocytes (-/-).  
The µM concentration of ERK inhibitor resulted in reduced expression of all three genes while 
inhibitor treatment at pM and nM concentrations did not effectively interrupt gene expression in 








































Figure 2. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2) 
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without 
p38 MAPK inhibitor SB203580 (70 µM, nM or pM), and then 1h incubation of thrombocytes (1 x 
107) at 41°C in the presence or absence of S. minnesota  lipopolysaccharide (LPS: 10 µg/mL).  
The mRNA expression of all three molecules varied relative to LPS and p38 MAPK inhibitor 










































































































Figure 3. Interleukin-6 (IL-6) (A), Interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2) 
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without 
ERK (25 µM, nM or pM), and then 1 h incubation of thrombocytes (1 x 107) at 41°C in the 
presence or absence of S. minnesota  lipopolysaccharide (LPS: 10 µg/mL).  The mRNA 
expression of all three molecules varied relative to LPS and p38 MAPK inhibitor treatment 









































































In chicken thrombocytes, stimulation with LPS leads to a number of inflammatory responses 
through TLR4-linked cytoplasmic pathways.  The current experiments demonstrated that 
expression of IL-6, IL-8, and COX-2 genes are mediat  by two of the three major MAPK 
signaling pathways.  Specifically, both ERK and p38 MAPK pathways regulate gene expression 
for these pro-inflammatory molecules. 
Previous work in our laboratory (Scott and Owens, 2008) has shown that LPS stimulates the 
NF-κB pathway of thrombocytes, resulting in increased expr ssion of IL-6 and COX-2 mRNA 
and PGE2 production.  It was also demonstrated that MEK1/2 inhibition negatively affected 
expression of COX-2, but not IL-6 mRNA.  In contras, downstream ERK inhibition in the 
current experiments negatively affected expression of both IL-6 and COX-2, in addition to IL-8.  
Furthermore, the p38 MAPK pathway, previously shown to be involved in pro-inflammatory 
molecule expression in other innate cells (Khatri and Sharma, 2006; Chen et al., 1999) was also 
involved in the chicken thrombocyte innate response. 
As reported by Scott and Owens (2008), IL-6 expression increased dramatically in response 
to LPS.  In the present experiment, too, there was a significant response, and this expression was 
suppressed by treatment with µM concentrations of both p38 and ERK inhibitors.  Furthermore, 
70 nM of p38 inhibitor suppressed the IL-6 response.  In a study using LPS-stimulated chicken 
heterophils, treatment with PD98059 reduced ERK concentrations (Kogut et al., 2007).  In 
contrast to Kogut et al. (2007), treatment of thromb cytes with 10 µM PD98059 in our laboratory 
did not result in significantly lowered IL-6 expression (Scott and Owens, 2008) as expected.  It is 
possible that the 10 µM concentration of PD98059 did not affect ERK activity enough to suppress 
the IL-6 response or that these are probable differences in pathway sensitivity of heterophils 





Treatments with pM and nM concentrations of ERK andp38 inhibitors were ineffective at 
suppressing the IL-6 response to LPS.  The IC50 of p38 MAPK inhibitor for human monocytes is 
50-100 nM (Gallagher et al., 1995), a concentration range that was marginally effective with 
chicken thrombocytes.  Seventy µM p38 inhibitor was effective at suppressing LPS-induced 
expression of IL-6.  The listed IC50 for ERK inhibitor is ≤ 25 µM for HeLa, A549, and SUM-159 
tumor cells (Kumar et al., 1999; Hancock et al., 2005).  This concentration was effective at 
suppressing the IL-6 response of chicken thrombocytes. 
In heterophils, stimulation with LPS results in increased mRNA expression of IL-6 along 
with IL-8 and IL-1β (Kogut et al., 2005).  Heterophil receptor-mediated phagocytosis also leads 
to increased expression of IL-6 and IL-8 (Kogut et al., 2003).  Multiple studies have demonstrated 
IL-6 production by heterophils of different genetic lines, both constitutively (Swaggerty et al, 
2004) and in response to stimulation with LPS (Kogut et al, 2006).  In mammals, this pro-
inflammatory cytokine stimulates neutrophil degranul tion and B-cell differentiation, and induces 
acute phase proteins (Akira et al, 1990; Kaiser et al, 2000; Swaggerty et al, 2006).  IL-6 also 
stimulates thrombopoiesis.  Administration of IL-6 to C57BL/10 mice resulted in increased levels 
of thrombopoietin (TPO) mRNA in the liver, along with increased TPO plasma levels (Kaser et 
al, 2001).  The increase in TPO mRNA was also accompanied by a significant increase in the 
number of circulating platelets (Kaser et al, 2001).  When TPO was neutralized in vivo via 
injection of anti-TPO polyclonal antibody, this platelet elevation was not seen, indicating that IL-
6 regulates platelet levels via TPO induction (Kaser et al, 2001). 
Though in this experiment expression of IL-8 mRNA increased significantly in response to 
treatment with LPS, treatment with pM and nM concentrations of both p38 and ERK inhibitors 
were ineffective at suppressing the LPS-induced IL-8 response.  However, treatment with 70 µM 





mRNA expression.  While thrombocytes are unique, terminal-stage cells, they apparently share 
many of the immunological signal pathways existing in other leukocytes. In general, CXC 
chemokines such as IL-8 act as chemoattractants for polymorphonuclear cells, while CC and C 
chemokines function in macrophage and lymphocyte attraction (Baggiolini et al., 1994; Luster, 
1998; Zlotnik and Yoshie, 2000; Zhang et al., 2003).  In neonatal chicks, infection with 
Salmonella enteritidis results in increased expression of CXCLi2, a chemokine synonymous to 
IL-8 that recruits heterophils (Kogut, 2002).   
LPS also stimulated thrombocyte expression of COX-2 mRNA, and this response was 
suppressed by µM concentrations of both inhibitors.  Scott and Owens (2008) previously 
demonstrated an increase in COX-2 mRNA expression by thrombocytes in response to LPS.  In 
macrophages, exposure to Infectious Bursal Disease Virus (IBDV) results in greater expression of 
COX-2 and IL-8 mRNA (Khatri and Sharma, 2006) and ihibition of p38 and NF-κB in these 
cells suppressed the COX-2 mRNA response.  IBDV infection has also been shown to stimulate 
production of IL-1β, IL-6, cMGF, and iNOS in chicken macrophages (Kim et al., 1998; Khatri et 
al., 2005).  In J774 macrophages, inhibition of p38attenuates LPS-induced COX-2 activity, and 
consequently inhibits the release of PGE2 (Chen et al., 1999).   
While microarray analysis is a valuable hypothesis-generating tool, the amount and reliability 
of pertinent information gained in this study was limited.  Microarray data indicated that the p38 
MAPK but not the ERK pathway regulates interleukin-8 expression.  This is in contrast to RT-
PCR results, which suggested that both pathways were involved in expression of this molecule 
upon TLR4 ligation.  The data for IL-6 expression was in accordance with RT-PCR data, 
indicating that both pathways regulate expression of this molecule.  No information on 





support the theory that the NFκB pathway in chicken thrombocytes, as in most other systems 
examined, predominates MAPK pathways in the inflammatory response to bacterial stimulation. 
The current experiments examined the effect of inhibiting two different MAPK pathways on 
production of a cytokine, a chemokine, and an enzyme involved in the innate response to 
bacterial LPS.  Both the ERK and p38 pathways begin with ligation of TLR4 by LPS.  The avian 
ERK pathway is not yet fully understood, but is know  to be Ras-dependent (Kogut et al., 2007).  
Ligation of TLR4 activates an undetermined signal mo ecule, which in turn promotes conversion 
of Ras-GDP to Ras-GTP.  Ras-GTP activates Raf1, which in turn activates MEK1/2.  MEK1/2 
phosphorylates and activates ERK1/2, which then phos rylates and activates Elk-1.  Elk-1 then 
enters the nucleus and acts as a transcription factor for pro-inflammatory molecules, like those 
examined in this study.  In the p38 MAPK pathway, ligation of TLR4 results in activation of 
TAK, which phosphorylates MEK3/6.  MEK3/6 in turn activates p38 (MAP Kinase 14).  p38 
activates a form of Elk which enters the nucleus and ctivates transcription of IL-6, IL-8 and 
COX-2. 
Treatment with 20 to 40 µM PD98059 inhibited phosphorylation of ERK1/2 in limbal 
epithelial cultures and suppressed production of IL-8, IL-1β, and TNF-α in response to exposure 
to hyperosmolar medium (Li et al., 2006).  In immortalized T/C28a2 human chondrocytes, 
activation of the ERK, p38 and JNK pathways resulted in enhanced expression of COX-2 and 
production of PGE2 (Nieminen et al., 2005).  The COX-2 and PGE2 responses were suppressed 
by treatment with PD98059.  Also, treatment with SB203580 inhibited COX-2 expression and 
subsequent PGE2 production at µM concentrations (Nieminen et al., 2005). 
Several models show the MAPK pathway involving p38 as the dominant pathway in pro-
inflammatory responses, with the ERK pathway involvement primarily devoted to cell growth 





study would contradict those models, as stimulation of thrombocytes with LPS resulted in 
increased expression of IL-6, IL-8 and COX-2 mRNA which were all inhibited by treatment with 
the ERK inhibitor (Fig. 6).  The involvement of the ERK MAPK pathway in pro-inflammatory 
responses is likely due to the fact that thrombocytes are terminal-stage cells that do not grow or 
differentiate.  They are short-lived and actively function only in immune responses.  The model 
for signaling in the thrombocyte (Fig. 6) is now expanded from that proposed by Scott and Owens 
(2008).  Our model includes two MAPK and the NF-κB pathways for expression of genes 
encoded for pro-inflammatory molecules.  The cytoplasmic signaling pathways in thrombocytes 
would appear to be primarily devoted to immunologic responses in support of inflammation since 
these cells express Toll-like receptors (Scott and Owens, 2008) and are poised to activate upon 























Figure 4. Diagram of LPS stimulation of thrombocyte TLR4-linked MAPK pathways leading to 
gene expression of IL-6, IL-8 and COX-2.  Both the ERK and p38 pathways lead to stimulation 
of gene expression for these pro-inflammatory molecules based upon inhibition of ERK and p38 
by respective inhibitors.  Additionally, results of Scott and Owens (2008) revealed the role of the 
NF-κB pathway in support of the pro-inflammatory response of the thrombocyte.  All three 
pathways would be considered major stimulation cascades for gene expression following Toll-
like receptor ligation.  Solid arrows represent direct steps in pathways.  Dashed arrows represent 





































APPENDIX 1: PRELIMINARY EXPERIMENTATION 
Both p38 MAPK and ERK inhibitors interfered with mRNA expression of LPS stimulated 
thrombocytes. 
In this preliminary experiment, using 70 µM p38 inhibitor on SCWL chicken 
thrombocytes, there were significant differences in IL-6, IL-8 and COX-2 mRNA expressions for 
LPS (+/-) treated cells compared to negative controls (-/-) and thrombocytes exposed to p38 
MAPK inhibitor (+/+) (Fig. A1A, B, and C).  Using 25 µM ERK inhibitor on SCWL chicken 
thrombocytes, there were significant differences in IL-6, IL-8 and COX-2 mRNA expression 
levels between control cells (-/-) and those treated with LPS (+/-) (Fig. A2A, B and C).  The 
expression levels of cells treated with ERK inhibitor and LPS (+/+) were well below the 





































Figure A1. Interleukin-6 (IL-6) (A), interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2) 
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without 
p38 MAPK inhibitor SB203580 (70 µM), and then 1h incubation of thrombocytes (1 x 107) at 
41°C in the presence or absence of S. minnesota  lipopolysaccharide (LPS: 10 µg/mL). The 
mRNA expression of all three varied relative to LPS and p38 MAPK inhibitor treatment 








































































































Figure A2. Interleukin-6 (IL-6) (A), interleukin-8 (IL-8) (B), and cyclooxygenase-2 (COX-2) 
mRNA expression (C) in chicken thrombocytes following 30 min pre-treatment with or without 
ERK inhibitor (25 µM), and then 1h incubation of thrombocytes (1 x 107) at 41°C in the presence 
or absence of S. minnesota  lipopolysaccharide (LPS: 10 µg/mL).  The mRNA expression of all 
three varied relative to LPS and ERK inhibitor treament combinations.  Data are presented as 




































































APPENDIX 2: MICROARRAY DATA 
Both p38 MAPK and ERK Inhibitors Interfere with mRNA Expression of Numerous Cytokines, 
Chemokines, and TLR-linked Signal Molecules in LPS-Stimulated Thrombocytes 
Data from experiments in our laboratory indicated intact ERK and p38 MAPK signal 
pathways in chicken thrombocytes.  With this knowledg , RNA samples were subjected to 
microarray analysis of approximately 4,000 genes.  Examples of affected gene expression can be 
found in Appendix 2.  While this analysis was intend d to expand our knowledge of the scope of 

















Accession # Con vs. LPS 
Con vs. p38 
Inh. 
LPS vs. LPS 
+ p38 Inhib. 
p38 Inh. vs. 
Inh. + LPS 
MD-2 XM_418301 - +1.869 +1.869  
TLR2 
(isoform 1) 
CK607640 -1.838  -1.736 -1.704 
TLR3 NM_001011691 +1.737 +1.893 +1.893  
TLR4 NM_001030693 +2.669  -  
TLR5 BI066471 +4.266  -1.748  
TLR7 BM440145 +2.336  - +1.679 
TLR15 CK611396 +7.316    
TAB1 NM_001006240 -2.288 -2.506 -2.506 +2.497 
NFκB (p50) CK608565 +2.638  -3.497  
MKK3 NM_001012787 -1.595    
p38 BQ038538 -2.212    
cFos CK607079 +2.385    
TRAF6 CK607050   -2.387 -2.227 
TAK1 BM426610   -1.605  
IkB NM_001001472   +2.085 +1.514 
 
Table A1. List of Toll-like receptor pathway-linked genes differentially expressed in untreated 
control chicken thrombocytes versus thrombocytes exposed to LPS, and p38 inhibitor.  
Expression was determined by microarray, and genes in the list exhibited at least a +/-1.5 fold 














 Gene Name 
Genbank 
Accession # Con vs. LPS 
Con vs. 
ERK Inh. 








CK607640 -1.838    
TLR3 NM_001011691 +1.737 +2.038   
TLR4 NM_001030693 +2.669    
TLR5 BI066471 +4.266 +2.164   
TLR7 BM440145 +2.336 -4.237  -2.398 
TLR21 CK609262  -9.091 -5.917  
TAB1 NM_001006240 -2.288 -1.637 +1.638  
NFκB (p50) CK608565 +2.638 +3.147   
MKK3 NM_001012787 -1.595    
p38 BQ038538 -2.212   +2.275 
cFos CK607079 +2.385  -1.898  
MyD88 CK613540  +1.548   
 
Table A2. List of Toll-like receptor pathway-linked genes differentially expressed in untreated 
control chicken thrombocytes verses thrombocytes exposed to LPS, and Erk inhibitor.  
Expression was determined by microarray, and genes in the list exhibited at least a +/-1.5 fold 

















Gene Name Genbank 
Accession # 
Con vs. LPS Con vs. p38 
Inh. 
LPS vs. LPS 
+ p38 Inhib. 
p38 Inh. vs. 
Inh. + LPS 
chCCL20 CK613680 +12.79 -2.439 -1.538 +1.198 
IL-1β CK607391 +5.756 +1.600 -2.770 -1.333 
iNOS CK611178 +5.744 +1.002 -2.392 -3.021 
MIP-1β CK611404 +5.548 -6.329 +1.346 +1.035 
IL-18 CK613996 +4.312 +6.088 -1.443 +1.040 
chCXCLi1(IL8) CK610286 +4.071 -2.899 +1.126 +1.246 
chCCLi1 CK609462 +2.612 +8.221 +1.182 +4.410 
IL-6 CK613692 +1.964 -1.376 -2.717  
IL-4 AJ621249 +1.773 -7.143   
IL-16 CK614630 +1.750 +1.421 +1.037 -1.639 
IL-12β AJ564201 -2.008 -1.105 +3.865  
PDGFβ mRNA CK609072 +1.268 +1.507 -1.062 +1.278 
chCCLi3 CK613216 -1.321 -2.387 +2.498 -1.122 
IL12α AY262751  -2.481   
chCCLi7 CK610423 +1.418 +2.305 -1.008 -2.037 
 
Table A3. List of cytokine and chemokine genes differentially expressed in untreated control 
chicken thrombocytes verses thrombocytes exposed to LPS, and p38 inhibitor.  Expression was 

















Gene Name Genbank 
Accession # 
Con vs. LPS Con vs. 
ERK Inh. 
LPS vs. LPS 
+ ERK 
Inhib. 
ERK Inh. vs. 
Inh. + LPS 
chCCL20 CK613680 +12.79 +1.352 -6.944 +1.361 
IL-1β CK607391 +5.756 +1.447 -1.456 +1.057 
iNOS CK611178 +5.744 +2.369 +1.041 +1.024 
MIP-1β CK611404 +5.548 +1.296 -3.021 +1.416 
IL-18 CK613996 +4.312 +4.59 +1.062 -1.002 
chCXCLi1(IL8) CK610286 +4.071 +1.369 -1.431 +4.789 
chCCLi1 CK609462 +2.612 +3.831 +1.399 -1.048 
IL-6 CK613692 +1.964 -1.357 -2.309 +1.152 
IL-4 AJ621249 +1.773 +1.105   
IL-16 CK614630 +1.750 +2.988 +1.786 +1.046 
IL-12β AJ564201 -2.008 -1.422 +2.516 +1.784 
PDGFβ mRNA CK609464 +1.268 +1.555 +1.25 +1.018 
chCCLi3 CK613216 -1.321 -1.337 -1.029 +1.258 
IL12α AY262751  -6.289   
chCCLi7 CK610423 +1.418 +1.627 +1.981 +2.196 
chCCL5 CK609464   -8.403  
 
Table A4. List of cytokine and chemokine genes differentially expressed in untreated control 
chicken thrombocytes verses thrombocytes exposed to LPS, and Erk inhibitor.  Expression was 
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